Galectin Therapeutics (GALT)
(Delayed Data from NSDQ)
$2.32 USD
+0.13 (5.94%)
Updated Aug 16, 2024 04:00 PM ET
After-Market: $2.31 -0.01 (-0.43%) 4:24 PM ET
3-Hold of 5 3
D Value D Growth D Momentum F VGM
Earnings News For GALT
-
Galectin Therapeutics Reports Financial Results for the Quarter Ended June 30, 2024 and Provides Business Update
-
Galectin Therapeutics Reports Financial Results for the Quarter Ended March 31, 2024 and Provides Business Update
-
UPDATE ? Galectin Therapeutics Reports Financial Results for the Quarter Ended September 30, 2023 and Provides Business Update
-
Galectin Therapeutics Reports Financial Results for the Quarter Ended September 30, 2023 and Provides Business Update
-
Galectin Therapeutics Reports Financial Results for the Quarter Ended June 30, 2023 and Provides Business Update
-
Galectin Therapeutics Reports Financial Results for the Quarter Ended March 31, 2023 and Provides Business Update
-
Galectin Therapeutics Reports Financial Results for the Quarter Ended September 30, 2022 and Provides Business Update